How Biopharma and community oncology are working together to solve healthcare’s toughest challenges and build a more resilient future for cancer care.
Safeguarding Cell and Gene Therapies with InspiroGene's Cold Chain Facility
Meeting the demands of ultra-sensitive treatments with purpose-built storage, automation and pharmacy integration.
Read Time
4.5 minutes
Key Points:
- Purpose-built cold chain facility designed exclusively for cell and gene therapies (CGTs), with advanced cryogenic and ultra-low temperature storages and automated retrieval systems.
- Integrated specialty pharmacy streamlines dispensing and accelerates time to treatment.
- Strategic location enables rapid, nationwide distribution for time-sensitive therapies.
- Scalable infrastructure ready to support the growing demand for CGT.
Cold Chain: Purpose-Built Just for CGT
What are the main challenges in delivering cell and gene therapies (CGTs)?
CGTs are highly sensitive and require critical logistical measures, such as precise handling, secure storage and rapid delivery, to name a few. Even the smallest disruptions in the supply chain can impact patient outcomes. It is vital to maintain product integrity, meet strict temperature requirements and deliver therapies quickly and reliably to treatment centers.
How does InspiroGene address these challenges?
InspiroGene recently opened a purpose-built cold chain storage and logistics space within the Clermont, Kentucky, distribution center designed to support the unique needs of CGT products. The facility features advanced cryogenic and ultra-low temperature storage systems, automated retrieval technology and real-time product management capabilities. The space also contains an onsite pharmacist, giving treatment centers greater flexibility in how medications are dispensed while significantly reducing supply chain risk.
What makes InspiroGene's facility unique?
The facility spans 12,000 square feet within a 1 million-square-foot distribution center and includes:
- Advanced cryogenic and ultra-low temperature storage systems, designed for maximum flexibility
- Automated retrieval technology, such as the Cryo Arc for Magenta Life Sciences, which minimizes manual handling and maintains product viability
- Dedicated kitting and relabeling areas
- Biologics in a Box, a co-located specialty pharmacy
- Built-in redundancies for enhanced security
- Dedicated shipping docks for faster delivery and reduced temperature risks
How does the facility ensure product integrity?
The facility uses automated monitoring and real-time product management capabilities to protect product integrity at every step. The Cryo Arc system reduces exposure to ambient temperatures during retrieval, maintaining product viability.
What role does the integrated specialty pharmacy play?
The onsite specialty pharmacy, licensed to dispense in all 50 states, streamlines the process by quickly dispensing therapies. This integration greatly reduces cold chain risks, eliminating an extra step in the supply chain and expediting time to treatment.
How does InspiroGene's facility support the growing demand for CGTs?
The facility is scalable and flexible, ready to adapt to the evolving CGT market. Its strategic location near major transportation hubs supports swift distribution across the U.S., crucial for time-sensitive therapies.
What benefits does InspiroGene offer to stakeholders?
By bringing together logistics, pharmacy services and cold chain expertise under one roof, InspiroGene accelerates the delivery of life-changing therapies. The integrated approach removes friction from the supply chain, empowering stakeholders to deliver therapies with confidence.
Why is InspiroGene considered a trusted partner in CGTs?
InspiroGene is widely recognized as a trusted ally in the CGT space because of its combination of expertise, infrastructure and integrated solutions. Our mission begins and ends with the patient.
We design every solution to remove barriers to care and support patients with the treatment they deserve. In the world of CGTs, every product represents a patient waiting for a life-changing therapy — and we never lose sight of that.
Related Stories
Meeting the demands of ultra-sensitive treatments with purpose-built storage, automation and pharmacy integration
In the third episode of our Always Advancing video series, learn how precision and personalized medicine are transforming cancer care – expanding access to clinical trials and novel treatments in communities.
Using ²ÝÝ®ÊÓƵ Compile’s analytics to transform how patients with rare blood disorders access specialized care across Indiana.
InspiroGene by ²ÝÝ®ÊÓƵ helps patients with rare and severe diseases access innovative cell and gene therapies through personalized support at every step of their journey.
In the fourth episode of our Always Advancing video series, discover how InspiroGene by ²ÝÝ®ÊÓƵ partners with biopharma to expand patient access to advanced therapies.
Explore the latest trends shaping the future of cell and gene therapy and learn what’s needed to ensure innovation reaches patients.
In the second episode of our Always Advancing series, we explore how ²ÝÝ®ÊÓƵ and biopharma are breaking barriers to accelerate access to lifesaving therapies.
By teaming up with Angels for Change, we’re helping patients navigate drug shortages and access lifesaving treatments.
Health Mart pharmacies play a key role in providing accessible flu and RSV vaccination services to communities nationwide.